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ABSTRACT 
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The use of organic arsenicals in polymer chemistry and biomaterials science is limited despite the 
distinctive and versatile chemistry of arsenic. The interchangeable oxidation states of arsenic and 
the subsequent changes in chemical properties makes it a promising candidate for redox responsive 
materials. Thus, reversible addition fragmentation chain transfer (RAFT) polymerization has been 
employed for the first time to synthesize thermoresponsive organic arsenical containing block 
copolymers. The polymers undergo simultaneous self-assembly and cross-linking, via the organic 
arsenical pendant groups, under reductive conditions (to reduce As(V) to As(III)) in the presence 
of polythiol reagents as cross-linkers. The formation of As-S bonds stabilises the nanoparticles 
formed (Dh = 19 - 29 nm) and enables the stability and responsivity to oxidative stress of the 
particles, in aqueous and model biological solutions, to be tuned as a function of the number of 
thiols in the cross-linker or the [SH]/[As] stoichiometric ratio. The parent block copolymers and 
nanoparticles are non-toxic in vitro and the tuneable responsivity of these nanoparticles and the 
(bio)chemical activity of organic arsenical reagents could be advantageous for targeted drug 
delivery and the other bio(nano)medical applications. To the best our knowledge, this is the first 
time that arsenic-thiolate (As-S) bonding has been employed for stimuli responsive cross-linking 
of polymeric nanoparticles. 
INTRODUCTION 
Self-assembly of block copolymers is an established method for the fabrication of polymeric 
nanomaterials.1 Fundamental research into the relationship between block copolymer composition 
and self-assembled morphology,2 in both bulk and solution, has facilitated the development of a 
new field of applied science with applications in fields including bio(nano)medicine,3 
biomaterials,4 nanotechnology5 and catalysis,6 amongst others. Progress in both fundamental and 
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applied research has been driven by advances in synthetic methods that enable the synthesis of 
block copolymers with exquisite control over the molecular weight and molecular weight 
distribution of each block. Living anionic polymerization7 provides optimal control over 
polymerization leading to discrete domains which can efficiently phase separate depending on the 
monomers employed. However, the sensitive nature of anionic polymerization limits the functional 
scope of the monomers that can be employed. The discovery and development of reversible 
deactivation radical polymerization (RDRP) techniques such as; reversible addition fragmentation 
chain transfer polymerization (RAFT),8 nitroxide mediated polymerization (NMP)9 and transition 
metal mediated methods e.g. atom transfer radical polymerization (ATRP)10 and single electron 
transfer living radical polymerization (SET-LRP),11 has addressed this limitation and greatly 
expanded the functional group tolerance. Furthermore, the most recent developments of these 
protocols allows the synthesis of (multi) block copolymers with excellent control over block 
copolymer composition in a variety of architectures including linear,12 telechelic,13 star14 and 
cyclic/tadpole-shaped15 polymers. 
 The behaviour of amphiphiles in aqueous solution can be rationalized from a 
thermodynamic perspective whereby interfacial interactions of the insoluble components are 
minimized, resulting in lower interfacial free energy. Under thermodynamic control, the position 
of equilibrium and therefore the stability or morphology of self-assembled block polymers can be 
manipulated by changes in concentration and temperature.16 In the context of bio(nano)medicine 
applications, a key property of self-assembled block copolymers is the stability of the resulting 
nanoparticles under the high dilution conditions imposed in vivo.17 The relative stability of self-
assembled amphiphiles can be inferred from the critical aggregation concentration (CAC),18 which 
is typically much lower for polymeric nanoparticles than those formulated using small molecule 
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amphiphiles (e.g. phospholipids). The stability can be further tuned according to the properties 
imposed by the monomers constituting the core and corona-forming blocks. For example, 
decreasing chain mobility (i.e. increasing Tg) within the core forming block can lead to kinetic 
trapping during self-assembly, which is the basis for crystallization-driven self-assembly.19 
Furthermore, non-covalent interactions such as hydrophobic,20 π-π21 or electrostatic interactions,22 
as well as hydrogen bonding23 and transition metal complexation24 can provide additional 
stabilization within core-forming blocks.  
Alternatively, cross-linking through the formation of covalent bonds within the core25 
and/or the corona,26 can result in enhanced stability. Covalent cross-linking results in the formation 
of either static (irreversibly) or dynamic bonds. The latter confers the potential for reversibility 
and responsivity, which can be engineered into polymers using functional vinyl-monomers 
compatible with RDRP protocols. For example, aldehydes/ketones for formation of imines,27 
oximes28 and hydazones,29 as well as disulfides30 and boronic acid/boronate esters31 are functional 
monomers that can respond to biological stimuli such as pH, redox and/or other specific 
biomarkers/biomolecules such as reactive oxygen species (ROS),32 sugars33 and enzymes.34 The 
ability to control stability in biological media and responsivity to biological stimuli is an important 
property to consider for drug delivery and other bio(nano)medical applications.35 Through this it 
is possible to manipulate release profiles, pharmacokinetics/dynamics of active pharmaceutical 
ingredients and also prevent synthetic materials from accumulating in the body which often 
correlates to lower toxicity.36   
Organic arsenicals are interesting candidates for dynamic cross-linking owing to the 
distinct reactivity arising from their interchangeable oxidation states (As(V) - As(III) – As(I)). The 
first example of this traces back to the first organic arsenical chemotherapeutic, arsphenamine 
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(Salvarsen), which is synthesized by reductive coupling of a monomeric organic arsenic acid 
(As(V)) reagent, and exists as homocyclic oligomers (As(I)n) comprised of multiple As-As 
bonds.37 The As-As bonds are prone to hydrolysis and oxidation and the first investigation into 
stabilizing nanoparticles derived from diblock copolymeric arsenicals explored the stability and 
responsivity of such particles in aqueous and model biological media (5 mM glutathione, 
GSH/H2O2).
38 It was shown that the aqueous stability increased and that the responsivity to GSH 
could be tuned as a function of the arsenic mole fraction within the polymer composition. 
Conversely, under simulated oxidative stress in the presence of H2O2, all the particles disassembled 
rapidly (< 1 hour) highlighting the lability of these formulations to hydrolysis and oxidation. 
In the case of arsphenamine, it is proposed that hydrolysis and oxidation of the As-As 
bonds is the mechanism for release of the active chemotherapeutic, which is thought to be a 
monomeric organic arsenous acid (As(III)) derivative. This hypothesis arises from the high affinity 
of As(III) for thiols, particularly proximal dithiols present in intracellular redox active proteins,39 
whereupon binding to As(III) can disrupt redox homeostasis,40 induce mitochondrial dysfunction41 
that ultimately leads to cell death.42 This has been exploited to develop organic arsenical based 
chemotherapeutics.43 The thermodynamics44 and nucleophilic exchangeability of arsenic-thiolate 
(As-S) bonding is well known, and is the basis for pro-fluorescent bis-arsenicals that bind to 
tetracysteine motifs through thiol exchange with ethane dithiol adducts.45 From a biomaterials 
perspective this has been exploited to develop functional polymer scaffolds for post-
polymerization modification,46  highly specific, efficient and reversible approach to 
protein/peptide conjugation,47 and nanoparticles presenting organic arsenical drugs as ligands for 
mitochondrial targeting.48 However, the affinity, efficiency and nucleophilic exchangeability of 
the arsenic-thiolate interaction is yet to be investigated as a strategy for cross-linking to formulate, 
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stabilize and tune the responsivity of polymeric nanoparticles. Herein, polythiol reagents are 
investigated as cross-linkers for simultaneous self-assembly and cross-linking of 
thermoresponsive block copolymeric arsenicals. The structure, stability and responsivity to thiol 
exchange and simulated oxidative stress is investigated relative to the labile As-As cross-linked 
system with a view to employing such particles for stimuli responsive drug delivery and other 
bio(nano)medical applications in the future.  
MATERIALS AND METHODS 
General procedure for RAFT polymerisation (for P1p) 
A typical synthesis of the first block is the following: CTA PABTC (24.8 mg, 0.1 mmol), PEGA480 
(1000 mg, 2.1 mmol), V601 (0.5 mg, 2.2 μmol) and trifluoroethanol (1.5 mL, 1 M monomer 
concentration) was charged into a vial equipped with a magnetic stirrer, the vial was then sealed 
with rubber septum and deoxygenated by a stream of bubbling nitrogen for 15 minutes with 
stirring. The vial was suspended in a preheated oil bath at 65 °C for 24 hrs. Reaction progress was 
monitored by 1H NMR and SEC. No purification was required before chain extension. 
A typical chain extension (for P1p) 
The vial with reaction mixture containing the first block (macroCTA) was cooled before opening 
to air. NIPAm (1136 mg, 10 mmol), AsAm(pin2) (644 mg, 1.4 mmol), V601 (1.26 mg, 5.5 2.2 
μmol) and trifluoroethanol (3.8 mL, 3 M monomer concentration) were added and the mixture was 
well stirred. The vial was then re-sealed with a rubber septum and deoxygenated by a stream of 
bubbling nitrogen for 15 minutes with stirring. The vial was suspended in a preheated oil bath at 
65 °C for 24 hrs. Reaction progress was monitored by 1H NMR and SEC. No purification was 
required before deprotection. 
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Deprotection AsAm(pin)2 units / removal of pinacol groups (P1 and P2)  
The polymerisation reaction mixture (P1p / P2p) was dialysed in 0.1 M HCl solution overnight 
before changing to deionised water and further dialysed for 24 hours in deionised water, changing 
the water up to 3 times. The dialysed polymer solution was lyophilised to yielded P1 as white 
powder (2.4 g, 85 % yield). Similarly, P2 was obtained as white powder (2.0 g, 94 % yield). 
General Procedure for Arsenic-thiolate cross-linked nanoparticle synthesis 
AsAm functional polymer (P1/P2, 100 mg) was dissolved in deoxygenated aqueous solution (10 
mL) of hypophosphorous acid (H3PO2, 10 wt%, 10 mg/mL polymer) and deoxygenated KI (1 vol% 
from a 3 wt % aq solution) was added. The solution was heated at 60 °C for 10 minutes before 
addition of the polythiol cross-linker. Stock solutions (100 mg/mL in dioxane) of cross-linkers 
were prepared and added to preassembled nanoparticle solution to synthesise the following; 
pentaerythritol tetrakis(3-mercaptopropionate (PTM), was used as a cross-linker to synthesise 
NPAs-S4 (12.4 mg, 123 µL of cross-linker solution, 7.5 eq with respect to P1) and to synthesis NPAs-
S4/2 (6.18 mg, 61.8 µL of cross-linker solution, 3.75 eq with respect to P1); trimethylolpropane 
tris(3-mercaptopropionate) (TTM) was used as a cross-linker to synthesise NPAs-S3 (13.5 mg, 135 
µL of cross-linker solution, 10 eq with respect to P1) and to synthesis NPAs-S3/2 (6.7 mg, 67.3 µL 
of cross-linker solution, 5 eq with respect to P1); hexa(ethylene glycol) dithiol (HDT) was used as 
a cross-linker to synthesise NPAs-S2 (11.5 mg, 115 µL of cross-linker solution, 15 eq with respect 
to P1). The cross-linking reaction was left for 2 hours at 60 °C. The resulting solution was dialysed 
(nMWCO 3.5 KDa) for 3 days with deionised water, changing the water twice a day to remove 
electrolytes and dioxane. The cross-linked particles were isolated by lyophilisation to obtain white 
solid (yielded approximately between 95 - 99%) and were readily dispersed in H2O. 
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General procedure for particle stability and disassembly. 
Polymer nanoparticles (1 mg/mL), were dissolved separately in deionised water, glutathione (5 
mM) and H2O2 (5 mM). The solutions were filtered through (450 μm nylon filters) into separate 
plastic cuvettes (with a lid) and incubated at 37 0C in water bath. Disassembly was monitored 
through the measurement of changes in particle size (Dh) as a function of time by DLS. 
Atomic Force Microscopy (AFM) 
AFM images were recorded on a Bruker Dimension Icon instrument operated in peak force tapping 
mode. The probes used were ScanAsyst silicon tips with a resonance frequency of 70 kHz and a 
spring constant of 0.4 N/m. Samples were prepared by drop casting 5 μl of a 1 mg/mL aqueous 
nanoparticle solution onto a freshly cleaved sheet of mica, left to stand for 30 seconds and then 
dried under a stream of Nitrogen. 
Transmission Electron Microscopy (TEM) 
Samples were prepared by placing a 400 mesh carbon coated Formvar copper grid onto a 20 µL 
droplet of aqueous nanoparticles (1 mg/mL) in a petri dish, leaving it for 10 minutes before 
drawing off the solution. The grid was then stained by placing onto a 20 µl droplet of aqueous 
solution of uranyl acetate (0.2 wt%), leaving it for 10 minutes before drawing off excess liquid and 
allowed to air-dry overnight. TEM images were acquired using a JEOL 2100 transmission electron 
microscope operating at a 200 kV accelerating voltage. Images were captured using Digital 
Micrograph® and analyzed with ImageJ. 
Cell viability 
Cell viability was assessed against MDA-231 (human breast adenocarcinoma) cell lines. Cells 
were seeded into a 96-well plate, (1.5 x 104 cells per well), cultured in basal medium DMEM 
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(Dublecco’s Modified Eagle Medium) with 10% foetal bovine serum and allowed to grow for 24 
hours. The medium was then replaced with fresh media contain As-functional nanoparticles (0.313, 
0.625, 1.25, 2.50, 5.00 mg/mL) prepared from parent solutions of As-functional nanoparticles in 
media (5 mg/mL). Cells were further incubated for 24 hours. The medium was replaced with fresh 
medium containing a solution of XTT (0.2 mg/mL) and N-methyl dibenzopyrazine methyl sulphate 
(250 μM) and incubated for 16 hours. Cells were then transferred to a plate reader and absorbance 
at 450 and 650 nm was assessed. 
RESULTS AND DISCUSSION 
In previous work, block copolymeric arsenicals were synthesised by aqueous SET-LRP and were 
subsequently shown to undergo simultaneous self-assembly and reductive cross-linking (As-As) 
at elevated temperature in a reductive environment (H3PO2/KI).38 Though aqueous SET-LRP is an 
ideal system for the polymerization of hydrophilic acrylamides and acrylates,49 hydrolysis of the 
ω-bromine end group50 can prove to be a limitation, and the use of relatively high concentrations 
of copper can add additional processing and purification steps. Having previously used RAFT 
polymerization for the homopolymerization of an organic arsenical acrylamide monomer (N-(4-
(2,2,3,3,7,7,8,8-octamethyl-1,4,6,9-tetraoxa-5λ5-arsaspiro[4.4]non-5-yl)-phenyl-2-propenamide; 
AsAm(pin)2)46 and considering the advantages, most notably greater monomer scope, RAFT was 
employed here to synthesise thermoresponsive block copolymeric arsenicals for the first time, 
expanding their utility and versatility in polymer synthesis. 
 To investigate the effect of cross-linking using polythiol reagents on the formation and 
stability of polymeric arsenical nanoparticles, two polymer compositions incorporating the arsenic 
monomer into either the core-forming block (P1) or corona-forming block (P2) were targeted. The 
targeted composition of P1 (PEGA20-b-[NIPAm70-co-AsAm10]) was selected based on our 
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previous work where these thermoresponsive block copolymeric arsenicals were capable of 
forming stable nanoparticles via the reductive coupling method.38 Likewise, the targeted 
composition of P2 ([PEGA15-co-AsAm5]-b-NIPAm80) was selected based on our previous work. 
This polymer did not form stable nanoparticles under reductive coupling but was investigated here 
to determine if the structures could be stabilised using potentially more robust polythiol cross-
linkers. 
 
Figure 1: Scheme for the synthesis thermoresponsive block copolymeric arsenicals P1 (PEGA22-
b-[NIPAm106-co-AsAm15]) and P2 ([PEGA17.5-co-AsAm5.5]-b-NIPAm97) by RAFT (top). SEC 
(DMF) of P1 and P2 showing: first block (black), chain extension (P1p, claret; P2p, red), after 
pinacol hydrolysis (P1, blue; P2, green) (bottom). See Table 1 for molecular weight data. 
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For the synthesis of P1 (PEGA20-b-[NIPAm70-co-AsAm10]), the polymerisation of the 
PEGA480 corona-forming block gave good control (Mn,th = 10800 gmol-1, Mn,SEC = 8900 gmol-1, D 
= 1.16) using 2-((butylthio)-carbonothioyl) thio propanoic acid (PABTC) as the RAFT agent. An 
initial monomer concentration (PEGA480) of 1 M and initiator (V601) concentration of 9 x 10-4 M 
([CTA]0/[I]0 = 50) led to near quantitative conversion (98%) at 65 °C after 24 hours. The 
conversion and degree of polymerization (DPn) was determined by 1H NMR (Figure S1) from the 
integral of the vinyl proton at 5.85 ppm and -CH3 of the Z-group belonging to the PABTC (δ = 
0.91 ppm). Chain extension using AsAm(pin)2 and NIPAm with a combined monomer 
concentration of 3 M, initiator concentration of 1 x 10-3 M and [MacroCTA]0/[I]0 = 16, reached 
full conversion with respect to both monomers after 24 hours. Incorporation of AsAm(pin2) was 
verified and quantified by 1H NMR through integration of the aromatic signal at 7.68 ppm 
furnishing the pinacol-protected polymer P1p with a final composition PEGA22-b-[NIPAm106-co-
AsAm(pin2)15]. The block copolymerisation was also successfully demonstrated by SEC analysis 
showing a shift to a higher molecular weight (Mn,th = 29600 gmol-1, Mn,SEC = 29300 gmol-1, D = 
1.27) (Figure 1, Table 1). 
 An identical approach was followed for the synthesis of P2 ([PEGA15-co-AsAm5]-b-
NIPAm80). A combined initial monomer concentration of 1 M for the PEGA and AsAm(pin)2 
monomers with PABTC and V601 (9 x 10-4 M) ([CTA]0/[I]0 = 39) gave quantitative conversion 
(99 %). The aromatic signal corresponding to the AsAm(pin2) monomer at 7.68 ppm was used to 
determine the proportion of AsAm(pin2) in the initial block (Figure S2). The aromatic peak at 7.80-
7.50 ppm, was then used as a reference for subsequent chain extension to determine the 
[NIPAm]/[macroCTA] and a targeted DPn = 80. The chain extension with NIPAm and 
[MacroCTA]0/[I]0 = 16 proceeded with quantitative monomer conversion furnishing the pinacol-
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protected polymer P2p with a composition of [PEGA17.5-co-AsAm(pin2)5.5]-b-NIPAm97. 
Successful chain extension was further demonstrated by the SEC analysis (Mn,th = 22100 gmol-1, 
Mn,SEC = 20500 gmol-1, D = 1.24) (Figure 1, Table 1). 
 To obtained the reactive block copolymeric arsenicals P1 and P2, the pinacol groups of the 
AsAm(pin2) were removed by dialysis against 0.1 M HCl and de-ionized water to obtain the 
arsenic acid (AsAm, As(V))) functional pendent groups. Removal of the pinacol group from P1p 
and P2p to furnish P1 and P2 respectively was confirmed by 1H NMR with disappearance of the 
pinacol -CH3 signals at 1.27 and 1.00 ppm (Figure S3). In the case of P1, SEC revealed an expected 
decrease in Mn,th resulting from loss of the pinacol groups (Mn,th = 27100 gmol-1, Mn,SEC = 20800 
gmol-1, D = 1.35). Interestingly, the deprotection of P2p to furnish P2 resulted in a higher apparent 
molecular weight (Mn,th = 21200 gmol-1, Mn,SEC = 30500 gmol-1, D = 1.35) (Figure 1, Table 1). This 
phenomenon was consistently observed in repeated syntheses of P2 and in the synthesis of related 
scaffolds where the mole fraction of AsAm incorporated into the corona-forming PEGA block was 
varied (unpublished). This suggests that incorporation of AsAm into the corona-forming block has 
greater influence on the hydrodynamic volume of the copolymeric arsenicals than when AsAm is 
incorporated into the core-forming block.  
Table 1. Arsenic functional block copolymers synthesised by RAFT.  
 Polymer Composition Polymerisation mixture (P1p, P2p) After deprotection 
Conv.a Mn,thb 
(g mol-1) 
Mn,SECc 
(g mol-1) 
Dc Mn,thb 
(g mol-1) 
Mn,SECc 
(g mol-1) 
Dc 
P1 P[PEGA22] 98 % 10800 8900 1.16    
 P[PEGA22 -b-(NIPAm106-co-
AsAm15)] 
> 99 % 29600 29300 1.27 26900 20800 1.35 
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P2 P[PEGA17.5-co-AsAm5.5] 98.5 % 11100 9000 1.15    
 P[(PEGA17.5-co-AsAm5.5)-b-
NIPAm97] 
> 99 % 22100 20500 1.24 21100 30500 1.40 
a 1H NMR, CDCl3; b Calculated using Eq 2, SI; c SEC, DMF 
 Prior to investigating the effect of polythiol cross-linking, the thermoresponsive behaviour 
and propensity for self-assembly of each copolymer was confirmed by variable temperature 
dynamic light scattering (DLS, 25-60 °C) in aqueous solutions (1 mg/mL). When the AsAm units 
were incorporated into the core-forming NIPAm block (P1), self-assembly occurred at T = 50 °C 
(Dh = 33 nm), and the nanoparticles contracted further with increasing temperature (Dh = 21 nm at 
T = 60 °C) (Figure 2).  With the AsAm units incorporated in the corona forming PEGA block (P2), 
self-assembly occurred at lower temperatures (T = 40 °C, Dh = 21 nm), with contraction again 
observed with increasing temperature (Dh = 15 nm, at 60 °C) (Figure 2), forming smaller 
aggregates across the temperature range compared to P1.  
 
Figure 2. Variable temperature DLS analysis of thermally induced self-assembly of P1 (A and B) 
and P2 (C and D) between 25 – 60 °C, in aqueous solution (1 mg/mL). 
 One of the benefits of cross-linking thermoresponsive self-assembled polymers is being 
able to follow the success of cross-linking using DLS by returning the temperature back to that 
which the polymers would otherwise dissemble to unimer’s without successful stabilisation. This 
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has previously been exemplified with nanostructures formed during polymerization induced 
thermal self-assembly (PITSA) of NIPAm, whereby covalent cross-linking at elevated 
temperatures results in retention of the nanostructures at ambient temperature.51 The reactivity of 
arsenic offers a number of potential cross-linking strategies. In our previous work,38 the simplest 
approach to cross-linking thermoresponsive block copolymeric arsenicals by simultaneous self-
assembly and reductive coupling, resulting in the formation of As-As bonds in the form of As(I)n 
homocycles, was sufficient to stabilise core-functional copolymers, but not corona-functional 
copolymers. Consistent with this work P2 was not stabilised by reductive coupling, whilst P1 was 
successfully cross-linked to yield stable polymer nanoparticles (NPAs(I)), as confirmed by DLS (Dh 
= 29 nm, Figure S4B), static light scattering (SLS, Nagg = 23, Figure S4E, S4F, Table 2), 
transmission electron microscopy (TEM, Figure S4C) and atomic force microscopy (AFM, Figure 
S4D).  
 The lability of the As-As bonds to hydrolysis and oxidation coupled with the high affinity 
of trivalent arsenic As(III) for thiol groups,44, 52 inspired investigation of polythiol reagents as 
cross-linkers of thermally self-assembled polymers, P1 and P2, through the formation of As-S 
bonds (Scheme 1). Although As(III) readily reacts with thiols to form As-S covalent bonds, 
pentavalent arsenic (As(V)) must first undergo reduction to As(III). This can be achieved via 
addition of excess thiol, with 2 equivalents required for reduction and a further 2 equivalents for 
bonding.46, 53 In the context of this work, it was hypothesised that this would limit the cross-linking 
efficiency by diminishing the number of reactive thiol groups due to their oxidation (during the 
initial reduction process) to disulfides. Alternatively, non-thiol reducing agents could be 
considered to achieve in-situ reduction prior to addition of the polythiol cross-linkers. With this in 
mind the reductive conditions reported previously (H3PO2, KI, 60 °C) were adopted to 
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simultaneously afford self-assembly and initiate reduction of As(V) to As(III). It was proposed that 
the introduction of polythiol cross-linkers would pull the redox equilibrium towards the thiol cross-
linked As(III) state, due to the formation of more enthalpically favoured As-S bonds. This 
hypothesis was verified by heating p-arsanilic acid under reductive conditions for 10 minutes prior 
to addition of a monothiol reagent (thiogylcerol, 2 eq), which resulted in the trapping of the As(III)-
bis-thiogycerol adduct of p-arsanilic acid (Figure S5). 
 
Scheme 1. Schematic representation of the proposed simultaneous self-assembly of and cross-
linking of P1 via polythiol reagents.  
 Pentaerythritol tetrakis(3-mercaptopropionate), (PTM), trimethylolpropane tris(3-
mercaptopropionate) (TTM) and hexa(ethylene glycol) dithiol (HDT) were identified as potential 
tetra- tri- and di-functional cross-linkers with similar interatomic distances between each thiol 
group (Scheme 1). As the pendant As(III) groups can form two bonds to thiols, and to investigate 
the effect of the thiol valency of the cross-linkers, the stoichiometry of cross-linker was initially 
set so that [SH]/[As] = 2. For example, P2 [PEGA17.5-co-AsAm5.5]-b-NIPAm97, which does not 
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form stable nanoparticles when subjected to reductive conditions alone, was initially reacted with 
tetra-functional PTM (2.75 eq i.e. 11 eq [SH] w.r.t. [As]) in an attempt to stabilise the resulting 
nanoparticles. However, the formation of stable As-S cross-linked nanoparticles was not observed, 
with DLS analysis at room temperature confirming the presence of only unimers (Figure S6). This 
is attributed to the relatively low functional density of the As-groups in the corona which is also 
naturally more diffuse than the core, thus limiting the proximity of As(III) groups during the cross-
linking process. 
 In contrast, when P1 (PEGA22-b-[NIPAm106-co-AsAm(pin2)15]) was heated and subjected 
to reductive conditions, addition of PTM (7.5 eq) furnished stable nanoparticles (NPAs-S4), as 
observed by DLS (Dh = 29 nm, PDI = 0.06) measured at room temperature (Figure 3A) and TEM 
(Figure 3B). Cross-linking through the functional pendent As-groups was confirmed by IR with 
changes in the region between 1000 – 700 cm-1 (Figure S7). Specifically, the decrease in intensity 
of the signal at 750 cm-1 and the appearance of the signal at 810 cm-1 are consistent with reduction 
and thiol substitution as reported in previous work.46 Static light scattering (SLS) was used to 
determine the absolute molecular weight (Mw,NP) from the Zimm plot and therefore the number of 
polymer chains per particle (Figure 3C, see SI for details). Interestingly, NPAs-S4 was estimated to 
have an aggregation number (Nagg) of 278 chains per particle (at infinite dilution), which was 
considerably higher than the As-As cross-linked nanoparticles (NPAs(I), Table 2). In previous work, 
the aqueous stability of NPAs(I) was shown to depend upon the mole fraction of AsAm present in 
the initial copolymer scaffolds.38 In this investigation, the copolymers have a similar AsAm mole 
fraction to those that disassembled at t > 48 hrs in the previous study. It is therefore proposed that 
the differences in Nagg arise due to partial hydrolysis and disassembly of the aggregates during 
dialysis of NPAs(I), which qualitatively reflects the relative stability of the As-S and As-As cross-
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linking in aqueous solution. The molecular weight of the nanoparticles decreased with 
concentration, indicative of inter-particle interactions and inter-particle crosslinking at higher 
concentration (Figure 3D). This was supported by the ratio of the radius of gyration and radius of 
hydration (ρ = Rg / Rh) which can provide topological information, with ρ = 0.778 for a compact 
hard sphere, and 2.36 for a stiff rod.54, 55 A ρ value of 1.39 was calculated for NPAs-S4 at 1 mg/mL, 
which increased to 2.04 at higher concentration (4 mg/mL), indicating a change in topology, 
deviating further from spherical geometry as a result of inter-nanoparticle clustering. The proposed 
inter-nanoparticle interaction was also observed by AFM, which indicates clustering of the 
particles (Figure 3E, 3F). 
 
Figure 3. A) Particle size distribution (DLS) of P1 (black) and NPAs-S4 (blue); B) TEM image of 
NPAs-S4 (scale bar = 100 nm); C) Zimm Plot for NPAs-S4 showing the evolution of KC/R as a 
function of q2 in aqueous solution from 0.25 – 4 mg/mL; D) Plot of the inverse of Mw,NP of NPAs-
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S4 as a function of concentration (see SI for details); E) AFM image of NPAs-S4 (scale bar = 400 
nm); F) AFM image of NPAs-S4 (scale bar = 100 nm). 
To synthesize nanoparticles that were less densely cross-linked, the amount of cross-linker 
was reduced to half the stoichiometry ([SH]/[As] = 1, i.e. 3.75 eq PTM w.r.t. P1). The resulting 
nanoparticles (NPAs-S4/2) were successfully prepared and stable at room temperature (Dh = 23 nm, 
PDI = 0.11, Figure 4A). Reducing the stoichiometry resulted in a decrease in Mw,NP and Nagg 
according to SLS analysis (Table 2), which also indicated that Mw,NP was largely independent of 
concentration (Figure S8). A ρ value of 1.13 was obtained which was lower NPAs-S4 (1.39 - 2.04, 
Table 2) across the concentration range, indicating that NPAs-S4/2 exhibited a more spherical 
topology. This was confirmed by AFM which revealed limited nanoparticle clustering (Figure 4B). 
 
Figure 4. A) Particle size distribution (DLS) of P1 (black) and NPAs-S4/2 (green); B) AFM image 
of NPAs-S4/2 (scale bar = 100 nm). 
 Based on their respective bond lengths, As-S56 bonds are more stable than As-As57 bonds 
in organic arsenicals. However, the As-S bonding can be dynamic in the presence of exchangeable 
thiols.47 The stability and responsivity of NPAs-S4 and NPAs-S4/2 to glutathione (5 mM, 37 °C) was 
therefore investigated. Both sets of nanoparticles remained intact, even after one week, as observed 
by no change in the hydrodynamic size by DLS analysis (Figure 5A, 5B). This represents a marked 
increase in stability to GSH compared to NPAs(I) which disassembled within 3 hours (Figure 5C).  
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Figure 5. Particle size distribution curves (DLS) for A) NPAs-S4; B) NPAs-S4/2; C) NPAs(I) (1 mg/mL) 
as a function of time in in aqueous GSH (5 mM). 
An alternative approach to tuning the cross-linking is through the thiol valency in the 
polythiol cross-linkers. When P1 was subjected to reductive conditions and tri-functional (TTM; 
10 eq w.r.t. P1) and di-functional (HDT; 15 eq w.r.t. P1) cross-linkers were added ([SH]/[As] = 2) 
to independent batches, stable nanoparticles NPAs-S3 (Dh = 25, PDI = 0.09, Figure S9A) and NPAs-
S2 (Dh = 19 nm, PDI = 0.11, Figure S10A) were retained at room temperature. According to SLS 
analysis NPAs-S3 were similar to NPAs-S4 exhibiting a slight decrease in Mw,NP and Nagg (Nagg = 204, 
Table 2), of which Mw,NP was shown to be dependent upon concentration (Figure S9C, S9D) 
resulting in ρ values from 1.28 (1 mg/mL) to 2.48 (4 mg/mL). Conversely, for NPAs-S2 both Mw,NP 
and Nagg were found to be significantly lower (Nagg = 26, Figure S10C, S10D) and the ρ values 
(1.60 - 1.64), although higher than anticipated, were similar across the concentration range (Table 
2). As the ρ values suggest, inter-particle clustering was evident by AFM of NPAs-S3 (Figure S9B) 
and NPAs-S2 (Figure S10B). Reducing the stoichiometry ([SH]/[As] = 1) during the TTM and HDT 
cross-linking had a profound effect. The nanoparticles prepared using TTM (NPAs-S3/2) exhibit the 
same trend as observed for NPAs-S4/2, i.e. lower Mw,NP, Nagg and less particle clustering compared 
to NPAs-S3 (Figure S11). Conversely, although those prepared using HDT (NPAs-S2/2) were initially 
stable at ambient temperature, purification by dialysis to remove any excess reagents resulted in 
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disassembly of NPAs-S2/2 (Figure S10A). 
Table 2. Light scattering analysis (DLS and SLS) of the As-nanoparticles. DLS was measured in 
aqueous solution (1 mg/mL). The ratio Rg/Rh at 4 mg/mL and 1 mg/mL is displayed for comparison. 
  SLS  DLS 
NP 
dn/dCa 
(mL/g) 
MW,NPb 
(g/mol) Naggc 
Rg /Rhd 
(4 mg/mL) 
Rg /Rhd 
(1 mg/mL) Dh (nm)  PDIe 
NPS4 0.137 7.5 x 106 277 2.04 1.39 29 0.06 
NPAs-S4/2 0.189 1.4 x 106 52 1.13 0.90 23 0.11 
NPAs-S3 0.133 5.5 x 106 203 2.48 1.28 25 0.09 
NPAs-S3/2 0.190 7.2 x 105 27 1.08 1.11 21 0.11 
NPAs-S2 0.174 7.0 x 105 26 1.64 1.60 19 0.11 
NPAs-S2/2 - - - - - 5.4 0.07 
NPAs(I) 0.164 6.3 x 105 23 3.42 1.27 29 0.12 
a Determined by measuring the refractive index over a range of concentrations (1.33, 0.66, 0.33, 
0.167 mg/mL); b Mw,NP was determined using Eq 3-5 (SI); c Nagg = Mw,NP/Mn,th; d Rg is the gradient 
of Zimm plots and Rh was determined as the size measured from the scattering angle at 90 ° from 
SLS; Measured using Eq 1 (SI). 
The trends in particle structure were reflected in the nanoparticle stability and initial 
responsivity to thiol exchange. Similar to NPAs-S4 and NPAs-S4/2, both NPAs-S3 and NPAs-S3/2 
remained intact even after a week in the presence of GSH (5 mM, 37 °C, Figure S12A, S12B). 
However, NPAs-S2 was found to be less stable than NPAs-S3 and NPAs-S4, disassembling between 48 
to 72 hours in the presence of GSH (5 mM, 37 °C, Figure S12C). This is attributed to the tetra- 
(PTM) and tri-thiol (TTM) cross-linkers affording greater cross-linking density and imposing a 
higher entropic barrier to thiol exchange with monothiol reagents such as GSH compared to the 
di-thiol (HDT) analogue. 
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 The dynamic redox chemistry of arsenic is a distinctive characteristic of organic and 
polymeric arsenicals that lends itself to application in the development of redox responsive 
(bio)nanomaterials. It is known that As(III) can be readily oxidise to As(V) by reactive oxygen 
species (ROS) such as hydrogen peroxide (H2O2).58 Suzuki et al have treated blood and organ 
lysates from animal models (Hamsters and Rats) with H2O2 to liberate As(III) bound proteins as 
arsenates (As(V)) for arsenic biodistribution and metabolite assays.59 Likewise, computational 
studies by Villamena et al suggests As(III) oxidation to As(V) by ROS species including hydrogen 
peroxide is exoergic, and highlight the possibility of arsenic cytotoxicity by GSH depletion due to 
the redox cycling events between GSH (As(V) reduction) and ROS (As(III) oxidation).60  
Here, the responsivity of the As-S cross-linked nanoparticles to H2O2 was investigated with 
the proposed response to As-S bond cleavage and oxidation (As(III) to As(V)) monitored as a 
function of the particle size using DLS (Figure 6). The nanoparticles stabilised by As-S cross-
linking (NPAs-S4, NPAs-S4/2, NPAs-S3, NPAs-S3/2, NPAs-S2) did not disassemble instantly, maintaining 
the hydrodynamic particle sizes over the first 3 hours. This is in contrast to the nanoparticles cross-
linked by reductive coupling only (NPAs(I)), which fully disassembled within 1 hour after addition 
of H2O2 (5 mM, 37 °C, Figure S13). A trend was observed relating the nanoparticle stability to the 
structure of the polythiol cross-linkers and the cross-linking density. The stability of the particles 
decreased with decreasing thiol valency in the cross-linkers ([SH] : [As] = 2; NPAs-S4 > NPAs-S3 > 
NPAs-S2) with NPAs-S4 (Figure 6B) undergoing disassembly over 44 hours and NPAs-S3 (Figure 6C) 
and NPAs-S2 (Figure 6D) disassembling over 18 hours and 6 hours respectively.   
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Figure 6. A) Schematic representation of the oxidative disassembly of the As-nanoparticles in the 
presence of H2O2; Particle size distribution curves (DLS) for B) NPAs-S4; C) NPAs-S3; D) NPAs-S2; 
E) NPAs-S4/2; F) NPAs-S3/2; as a function of time in in aqueous H2O2 (5 mM). 
 When the cross-linking density was reduced ([SH] : [As] = 1; NPAs-S4/2 and NPAs-S3/2) the 
stability was reduced further with the onset of disassembly occurring within 3 hours (Figure 6E, 
6F). This trend can be attributed to the thiol valency in the cross-linkers i.e. increasing valency 
PTM > TTM > HDT increases the likelihood of inter-chain As-S bonds forming, constituting cross-
linking, which have to be broken under the oxidative conditions. Intra-chain As-S bonding is also 
possible, and this will have a more detrimental effect when di-thiol HDT is employed (NPAs-S2) as 
a single intra-chain reaction will consume both the thiol groups at the expense of cross-linking 
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However, when PTM and TTM are employed (NPAs-S4 and NPAs-S3), there are latent thiol groups 
available for cross-linking should an intra-chain reaction occur. These results demonstrate for the 
first time that nanoparticles compromised of polymeric arsenicals, cross-linked via As-S bonds 
have tuneable responsivity to H2O2, which is an attractive stimulus for drug delivery, particularly 
as a responsive linker for peroxisomes targeted delivery is also particularly interesting, especially 
in intracellular infections.61 Furthermore, H2O2 is indigenously produced inside cells for natural 
cellular processing62 and its concentration is increased in environments of oxidative stress which 
occurs in response to inflammation associated with a number of disease states including cancer 
and atherosclerosis and cystic fibrosis. 
 
Figure 7. In vitro cell viability of polymer P1 and the As-nanoparticles (XTT viability assay using 
MDA cell line). 
 Finally, to dispel concerns regarding the toxicity of organic and polymeric arsenicals, 
which are known to be less toxic than inorganic counterparts, in vitro toxicity of the polymeric 
arsenical P1 and the resulting nanoparticles was determined using a standard XTT assay with a 
human breast adenocarcinoma cell line (MDA-231). Using an identical protocol, polymeric 
arsenical scaffolds have been shown to be non-toxic between 2 – 20 μM against MDA-231, whilst 
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nanoparticles derived from thermoresponsive block copolymeric arsenicals, similar to those 
reported here but consisting of As-As cross-linking, were also non-toxic up to 2 mg/mL against a 
Prostate cancer cell line (PC3). In this work P1 was non-toxic up to 5 mg/mL and the nanoparticles 
were non-toxic up to 2 mg/mL with the exception of the NPAs-S2 which showed a decrease in cell 
viability at concentration > 0.2 mg/mL (Figure 7).  This is attributed to the lower stability of NPAs-
S2 leading to an earlier onset of disassembly, with the products of the disassembly being responsible 
for the change in viability. The origin of the toxicity is not known at this stage but the released 
cross-linker is implicated considering that P1 is non-toxic over the concentration range. Despite 
this result, and since it occurs at high concentration (from a clinical perspective), these results 
support the potential of using polymeric arsenicals as a platform for stimuli responsive drug 
delivery.  
CONCLUSIONS   
Thermoresponsive block copolymeric arsenicals comprised of PEGA480 and NIPAm, with 
incorporation of organic arsenical acrylamide monomer (AsAm(pin2)) into either the core-forming 
NIPAm block (PEGA22-b-(NIPAm106-co-AsAm(pin2)15, P1p) or the corona-forming PEGA block 
([PEGA17.5-co-AsAm(pin2)5.5]-b-NIPAm97, P2p), have been synthesised by RAFT for the first 
time. Removal of the pinacol groups of AsAm(pin2) furnished reactive As(V)-functional groups 
and the resulting polymers (P1/P2) formed nanoparticles at elevated temperatures. The reactive 
As(V)-functional groups were targeted for cross-linking under reductive conditions (H3PO2, KI, 
60 °C) in the presence of polythiol reagents (PTM, TTM, HDT) exploiting the high affinity of the 
As(III) for thiols and affording cross-linking through the formation of As(III)-S bonds. The 
corona-functional polymer P2 was not able to be stabilised even in the presence of tetra-thiol cross-
linker PTM and targeting 100% cross-linking ([SH] : [As] = 2). However, the core-functional 
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polymer P1 formed stable nanoparticles in the presence of tetra- (PTM, NPAs-S4), tri- (TTM, NPAs-
S3) and di-thiol (HDT, NPAs-S2) cross-linkers ([SH] : [As] = 2), which were more stable than 
analogous nanoparticles cross-linked by complete reductive coupling via As-As bond formation 
NPAs(I). Characterisation of the nanoparticles by SLS, AFM and TEM revealed that Nagg and  Rg/Rh 
increased as a function of concentration for NPAs-S4 and NPAs-S3 which was manifest as changes in 
nanoparticle topology as a result of inter-particle interactions and aggregation. Conversely, NPAs-
S2 and nanoparticles prepared targeting 50% cross-linking ([SH] : [As] = 1; NPAs-S4/2, NPAs-S3/2) 
exhibited more spherical structures and showed little change in Nagg and  Rg/Rh. With respect to 
stability and responsivity of these nanoparticles only NPAs-S2 was shown to disassemble in the 
presence GSH (5 mM, 37 °C) which occurred over 72 hours. In contrast, a trend was observed 
pertaining to disassembly under conditions mimicking oxidative stress H2O2 (5 mM, 37 °C), 
whereby the stability of the particles followed the trend NPAs-S4 > NPAs-S3 > NPAs-S2 > NPAs-S4/2 ≈ 
NPAs-S3/2. To the best of our knowledge this is the first report in the literature that As-S bonding 
has been exploited to cross-link polymeric nanoparticles that are responsive to oxidative stress. 
The diverse chemistry and non-toxic nature of the polymeric arsenicals and nanoparticles 
demonstrated here and in our previous works, combined with the potential synergy with respect to 
biological activity, strengthens the case for broader acceptance and adoption of polymeric 
arsenicals as a functional and responsive platform for biomaterials science.  
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